$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Quaternary derivatives of noroxymorphone which relieve nausea and emesis 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/44
출원번호 US-0837399 (1986-03-07)
발명자 / 주소
  • Goldberg Leon I. (Chicago IL)
출원인 / 주소
  • University of Chicago (Chicago IL 02)
인용정보 피인용 횟수 : 123  인용 특허 : 1

초록

Quaternary derivatives of noroxymorphone are used to prevent or relieve nausea and emesis associated with the use of narcotic analgesics without interfering with the analgesic activity of the drugs. A particularly preferred compound is methylnaltrexone. The compound is administered in a concentratio

대표청구항

A method for preventing or relieving nausea and emesis associated with the use of narcotic analgesics in warm-blooded animals, which comprises administering to an animal prone towards nausea or emesis on receiving narcotic analgesics, an effective amount of at least one nausea and emesis relieving c

이 특허에 인용된 특허 (1)

  1. Goldberg Leon I. (Chicago IL) Merz Herbert (Ingelheim am Rhein DEX) Stockhaus Klaus (Bingen DEX), Quaternary derivatives of noroxymorphone which relieve intestinal immobility.

이 특허를 인용한 특허 (123)

  1. Boyd, Thomas A.; Wagoner, Howard; Sanghvi, Suketu P.; Verbicky, Christopher; Andruski, Stephen, (.
  2. Boyd, Thomas A.; Wagoner, Howard; Sanghvi, Suketu P.; Verbicky, Christopher; Andruski, Stephen, (S)--methylnaltrexone.
  3. Boyd, Thomas A.; Wagoner, Howard; Sanghvi, Suketu P.; Verbicky, Christopher; Andruski, Stephen, (S)-N-methylnaltrexone.
  4. Shah,Syed M.; Ali,Kadum A.; Kong,FangMing; Zhu,Tianmin; Gombar,Charles T., 6-carboxy-normorphinan derivatives, synthesis and uses thereof.
  5. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist.
  6. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist.
  7. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  8. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  9. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  10. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  11. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  12. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  13. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  14. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  15. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  16. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  17. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  18. Mehta, Atul M., Abuse-resistant oral dosage forms and method of use thereof.
  19. Mehta, Atul M., Abuse-resistant oral dosage forms and method of use thereof.
  20. Mehta, Atul M., Abuse-resistant oral dosage forms and method of use thereof.
  21. Bentley, Michael D.; Viegas, Tacey X.; Goodin, Richard R.; Cheng, Lin; Zhao, Xuan, Chemically modified small molecules.
  22. Bentley, Michael D.; Viegas, Tacey X.; Goodin, Richard R.; Cheng, Lin; Zhao, Xuan, Chemically modified small molecules.
  23. Bentley, Michael D.; Viegas, Tacey X.; Goodin, Richard R.; Cheng, Lin; Zhao, Xuan, Chemically modified small molecules.
  24. Fishburn, C. Simone; Lechuga-Ballesteros, David; Viegas, Tacey; Kuo, Mei-Chang; Song, Yuan; Gursahani, Hema; Leach, Chester, Chemically modified small molecules.
  25. Sadée, Wolfgang; Bilsky, Edward; Yancey-Wrona, Janet, Combination analgesic employing opioid agonist and neutral antagonist.
  26. Sadée, Wolfgang; Bilsky, Edward; Yancey-Wrona, Janet, Combination analgesic employing opioid agonist and neutral antagonist.
  27. Sadée, Wolfgang; Bilsky, Edward; Yancey-Wrona, Janet, Combination analgesic employing opioid and neutral antagonist.
  28. Von Coburg, Yvonne; Reimer, Karen; Oksche, Alexander; Holzer, Peter, Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation.
  29. Oshlack, Benjamin; Wright, Curtis, Controlled-release compositions containing opioid agonist and antagonist.
  30. Smolenskaya, Valeriya N.; Al Shareffi, Kadum A.; Perez, Julio; Shah, Syed M.; Boyd, Thomas A., Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof.
  31. Smolenskaya, Valeriya N.; Al Shareffi, Kadum A.; Perez, Julio; Shah, Syed M.; Boyd, Thomas A., Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof.
  32. Danagher, Helen Kathleen; Hayes, Geoffrey Gerard; Heun, Gerhard Josef; Mohammad, Hassan; Walden, Malcolm; Whitehouse, Jonathon Oliver, Immediate release pharmaceutical compositions comprising oxycodone and naloxone.
  33. Danagher, Helen Kathleen; Hayes, Geoffrey Gerard; Heun, Gerhard Josef; Mohammad, Hassan; Walden, Malcolm; Whitehouse, Jonathon Oliver, Immediate release pharmaceutical compositions comprising oxycodone and naloxone.
  34. Brögmann, Bianca; Muhlau, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  35. Brögmann, Bianca; Mühlah, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  36. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  37. Leyendecker, Petra; Hopp, Michael; Drews, Axel, Method and device for the assessment of bowel function.
  38. Palermo Philip J. ; Colucci Robert D. ; Kaiko Robert F., Method of preventing abuse of opioid dosage forms.
  39. Palermo, Philip J.; Kaiko, Robert F.; Colucci, Robert D., Method of preventing abuse of opioid dosage forms.
  40. Eswara Amruta R. ; Muni Neal ; Schneider F. Howard ; Mione Peter J., Methods and articles of manufacture for nicotine cessation and monitoring nicotine use.
  41. John J. Farrar, Methods and compositions involving opioids and antagonists thereof.
  42. John J. Farrar ; Peter J. Schied ; William K. Schmidt ; Randall L. Carpenter, Methods for the treatment and prevention of ileus.
  43. Farrar, John J.; Schied, Peter J.; Schmidt, William K.; Carpenter, Randall L., Methods for the treatment or inhibition of ileus.
  44. Barrett R. Cooper, Methods for treating opiate intolerance.
  45. Breder, Christopher; Wright, Curtis; Oshlack, Benjamin, Opiod agonist formulations with releasable and sequestered antagonist.
  46. Kaiko,Robert F.; Colucci,Robert D., Opioid agonist / antagonist combinations.
  47. Breder, Christopher; Wright, Curtis; Oshlack, Benjamin, Opioid agonist formulations with releasable and sequestered antagonist.
  48. Breder, Christopher; Wright, Curtis; Oshlack, Benjamin, Opioid agonist formulations with releasable and sequestered antagonist.
  49. Breder, Christopher; Wright, Curtis; Oshlack, Benjamin, Opioid agonist formulations with releasable and sequestered antagonist.
  50. Kaiko Robert F. ; Colucci Robert D., Opioid agonist/antagonist combinations.
  51. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  52. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  53. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  54. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  55. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  56. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  57. Kaiko,Robert F.; Colucci,Robert D., Opioid agonist/antagonist combinations.
  58. Robert F. Kaiko ; Robert D. Colucci, Opioid agonist/antagonist combinations.
  59. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/opioid antagonist/acetaminophen combinations.
  60. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/opioid antagonist/acetaminophen combinations.
  61. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/opioid antagonist/acetaminophen combinations.
  62. Robert F. Kaiko ; Robert D. Colucci, Opioid agonist/opioid antagonist/acetaminophen combinations.
  63. Fleischer, Wolfgang; Reimer, Karen; Leyendecker, Petra, Opioids for the treatment of the chronic obstructive pulmonary disease (COPD).
  64. Wright, IV, Curtis; Carpanzano, Anthony E., Oral dosage form comprising a therapeutic agent and an adverse-effect agent.
  65. Wright, IV,Curtis; Carpanzano,Anthony E., Oral dosage form comprising a therapeutic agent and an adverse-effect agent.
  66. Shah, Syed M.; Diorio, Christopher Richard; Ehrnsperger, Eric C.; Meng, Xu; Al Shareffi, Kadum A.; Cohen, Jonathan Marc, Oral formulations and lipophilic salts of methylnaltrexone.
  67. Avey, Alfred A.; Chandrasekaren, Appavu; Doshan, Harold D.; Perez, Julio; Rotshteyn, Yakov, Peripheral opioid receptor antagonists and uses thereof.
  68. Avey, Alfred A.; Chandrasekaren, Appavu; Doshan, Harold D.; Perez, Julio; Rotshteyn, Yakov, Peripheral opioid receptor antagonists and uses thereof.
  69. Bazhina, Nataliya; Donato, III, George Joseph; Fabian, Steven R.; Lokhnauth, John; Megati, Sreenivasulu; Melucci, Charles K.; Ofslager, Christian; Patel, Niketa; Radebaugh, Galen; Shah, Syed M.; Szeliga, Jan; Zhang, Huyi; Zhu, Tianmin, Peripheral opioid receptor antagonists and uses thereof.
  70. Bazhina, Nataliya; Donato, III, George Joseph; Fabian, Steven R.; Lokhnauth, John; Megati, Sreenivasulu; Melucci, Charles; Ofslager, Christian; Patel, Niketa; Radebaugh, Galen; Shah, Syed M.; Szeliga, Jan; Zhang, Huyi; Zhu, Tianmin, Peripheral opioid receptor antagonists and uses thereof.
  71. Bazhina, Nataliya; Donato, III, George Joseph; Fabian, Steven R.; Lokhnauth, John; Megati, Sreenivasulu; Melucci, Charles; Ofslager, Christian; Patel, Niketa; Radebaugh, Galen; Shah, Syed M.; Szeliga, Jan; Zhang, Huyi; Zhu, Tianmin, Peripheral opioid receptor antagonists and uses thereof.
  72. Bazhina, Nataliya; Donato, III, George Joseph; Fabian, Steven R.; Lokhnauth, John; Megati, Sreenivasulu; Melucci, Charles; Ofslager, Christian; Patel, Niketa; Radebaugh, Galen; Shah, Syed M.; Szeliga, Jan; Zhang, Huyi; Zhu, Tianmin, Peripheral opioid receptor antagonists and uses thereof.
  73. Bazhina, Nataliya; Donato, III, George Joseph; Fabian, Steven R.; Lokhnauth, John; Megati, Sreenivasulu; Melucci, Charles; Ofslager, Christian; Patel, Niketa; Radebaugh, Galen; Shah, Syed M.; Szeliga, Jan; Zhang, Huyi; Zhu, Tianmin, Peripheral opioid receptor antagonists and uses thereof.
  74. Bazhina, Nataliya; Donato, III, George Joseph; Fabian, Steven R.; Lokhnauth, John; Megati, Sreenivasulu; Melucci, Charles; Ofslager, Christian; Patel, Niketa; Radebaugh, Galen; Shah, Syed M.; Szeliga, Jan; Zhang, Huyi; Zhu, Tianmin, Peripheral opioid receptor antagonists and uses thereof.
  75. Bazhina, Nataliya; Donato, III, George Joseph; Fabian, Steven R.; Lokhnauth, John; Megati, Sreenivasulu; Melucci, Charles; Ofslager, Christian; Patel, Niketa; Radebaugh, Galen; Shah, Syed M.; Szeliga, Jan; Zhang, Huyi; Zhu, Tianmin, Peripheral opioid receptor antagonists and uses thereof.
  76. Melucci, Charles K.; Lokhnauth, John, Peripheral opioid receptor antagonists and uses thereof.
  77. Melucci, Charles K.; Lokhnauth, John, Peripheral opioid receptor antagonists and uses thereof.
  78. Liang, Alfred; Matthews, Frank; Boehm, Garth; Tang, Lijuan; Johnson, Frank; Stauffer, Joseph, Pharmaceutical composition.
  79. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical composition.
  80. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical compositions.
  81. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical compositions for the deterrence and/or prevention of abuse.
  82. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Pharmaceutical preparation containing oxycodone and naloxone.
  83. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Pharmaceutical preparation containing oxycodone and naloxone.
  84. Oshlack, Benjamin; Van Buskirk, Glenn; Chasin, Mark; Huang, Hua-Pin; Vashi, Vijay, Pharmaceutical product comprising a sequestered agent.
  85. Oshlack, Benjamin; Van Buskirk, Glenn; Chasin, Mark; Huang, Hua-Pin; Vashi, Vijay, Pharmaceutical products.
  86. Bentley, Michael David; Roberts, Michael James; Shen, Xiaoming; Cheng, Lin, Polymer conjugates of opioid antagonists.
  87. Bentley, Michael David; Roberts, Michael James; Shen, Xiaoming; Cheng, Lin, Polymer conjugates of opioid antagonists.
  88. Bentley,Michael David; Roberts,Michael James; Shen,Xiaoming; Cheng,Lin, Polymer conjugates of opioid antagonists.
  89. Roberts, Michael James; Shen, Xiaoming; Cheng, Lin; Bentley, Michael David, Polymer conjugates of opioid antagonists.
  90. Avey, Alfred A.; Perez, Julio, Preparation and use of (R),(R)-2,2′-bis-methylnaltrexone.
  91. Avey, Alfred A.; Perez, Julio, Preparation and use of (R),(R)-2,2′-bis-methylnaltrexone.
  92. Goldberg Leon I. (Chicago IL), Quaternary derivatives of noroxymorphone which relieve nausea and emesis.
  93. Breder, Christopher; Oshlack, Benjamin; Wright, Curtis, Sequestered antagonist formulations.
  94. Breder, Christopher; Oshlack, Benjamin; Wright, Curtis, Sequestered antagonist formulations.
  95. Boehm, Garth, Sequestering subunit and related compositions and methods.
  96. Boehm, Garth, Sequestering subunit and related compositions and methods.
  97. Sanghvi, Suketu P.; Boyd, Thomas A., Stable methylnaltrexone preparation.
  98. Sanghvi, Suketu P.; Boyd, Thomas A., Stable pharmaceutical formulations of methylnaltrexone.
  99. Doshan, Harold D.; Perez, Julio, Synthesis of (R)-N-methylnaltrexone.
  100. Doshan, Harold D.; Perez, Julio, Synthesis of R-N-methylnaltrexone.
  101. Doshan, Harold D.; Perez, Julio, Synthesis of R-N-methylnaltrexone.
  102. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper resistant oral opioid agonist formulations.
  103. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  104. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  105. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  106. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  107. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  108. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  109. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  110. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  111. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  112. Oshlack, Benjamin; Wright, Curtis; Haddox, J.David, Tamper-resistant oral opioid agonist formulations.
  113. Oshlack, Benjamin; Wright, Curtis; Haddox, J.David, Tamper-resistant oral opioid agonist formulations.
  114. Oshlack, Benjamin; Wright, Curtis; Haddox, J.David, Tamper-resistant oral opioid agonist formulations.
  115. Moss, Jonathan; Singleton, Patrick A., Treatment with opioid antagonists and mTOR inhibitors.
  116. Moss, Jonathan; Singleton, Patrick A., Treatment with opioid antagonists and mTOR inhibitors.
  117. Foss, Joseph F.; Roizen, Michael F.; Moss, Jonathan; Yuan, Chun-Su; Drell, William, Use of methylnaltrexone and related compounds.
  118. Moss, Jonathan; Lingen, Mark; Singleton, Patrick A.; Garcia, Joe G. N., Use of opioid antagonists.
  119. Moss, Jonathan; Lingen, Mark; Singleton, Patrick A.; Garcia, Joe G. N., Use of opioid antagonists.
  120. Moss, Jonathan; Lingen, Mark; Singleton, Patrick A.; Garcia, Joe G. N., Use of opioid antagonists to attenuate endothelial cell proliferation and migration.
  121. Moss, Jonathan; Lingen, Mark; Singleton, Patrick A.; Garcia, Joe G. N.; Yuan, Chun-Su, Use of opioid antagonists to attenuate endothelial cell proliferation and migration.
  122. Moss, Jonathan; Lingen, Mark; Singleton, Patrick A.; Garcia, Joe G. N.; Yuan, Chun-Su, Use of opioid antagonists to attenuate endothelial cell proliferation and migration.
  123. Moss, Jonathan; Lingen, Mark; Singleton, Patrick A.; Garcia, Joe G. N.; Yuan, Chun-Su, Use of opioid antagonists to attenuate endothelial cell proliferation and migration.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로